INNPFInnocan Pharma Corp.

About Innocan Pharma Corp. (INNPF)

Innocan Pharma Corp. (INNPF) is a Drug Manufacturers - Specialty & Generic company headquartered in Calgary, AB, Canada whose shares trade over-the-counter on the OTCQB tier.

The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

Products and services

cosmetic products

INNPF key facts

Ticker symbol

INNPF

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Calgary, AB, Canada

Country of incorporation

CA

Year of incorporation

2018

Employees

9

Estimated market cap

$40.94M (as of May 12, 2025)

Shares outstanding

292,420,157

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Innocan Pharma Corp. leadership

• Iris Bincovich — CEO
• Roni A Kamhi — COO
• Nelson Halpern,FCPA,FCA,TEP — CFO
• Tzahi Harel — Finance Manager

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with I